July 22, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against OGN

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Organon & Co. regarding a class action lawsuit due to alleged misleading statements and concealment of material facts related to the company's capital allocation and dividend strategy [1][3]. Summary by Sections Allegations - The complaint alleges that Organon & Co. provided overly positive statements to investors while concealing adverse facts about its priorities, particularly regarding capital allocation and a significant debt reduction strategy following the acquisition of Dermavant [3]. - The company's regular quarterly dividend was reduced by 70%, which was not disclosed to investors prior to the announcement [3]. Stock Price Impact - Following the announcement of the dividend cut, Organon's stock price plummeted from $12.93 per share on April 30, 2025, to$9.45 per share on May 1, 2025, marking a decline of over 27% in just one day [3]. Class Action Details - The class period for the lawsuit is defined as October 31, 2024, to April 30, 2025, and shareholders are encouraged to register for participation in the class action by the deadline of July 22, 2025 [4]. - Shareholders who register will receive updates through a portfolio monitoring software regarding the status of the case [4]. Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered losses due to deceitful practices and seeks recovery for those affected by misleading statements that inflated the company's stock price [5].